Keyword: Lupin

Markets & Companies

Potential In Eastern Europe

29.07.2014 - Over the past five years, emerging markets have experienced some of the highest pharmaceutical market growth rates, a trend that is expected to continue. Central Eastern Europe...

News

Actavis to Sell Generic Yaz Birth Control After Ruling

17.04.2013 - Pharmaceutical company Actavis said on Tuesday that it would once again sell a generic version of Bayer's Yaz after an appeals court ruled that Bayer's patent for the oral...

News

The Future of Pharma

11.04.2013 - The Rise Of Generics - In 2011, CMS Pharma was invited to take part in a conference in Mumbai to discuss the emergence of "supergenerics," a new form of generic drugs with improved...

News

Slow Approvals Put India's Drug Trials Industry at Risk

13.02.2013 - Slower government approval for testing new medicines is threatening India's aspirations to be a fast-growing, low-cost hub for clinical trials, and has prompted some drugs firms to...

News

Bayer Sues Lupin Over Generic Birth Control Pill

30.11.2012 - German drugmaker Bayer has filed a lawsuit in the United States against Indian generic drug maker Lupin, to prevent it from selling a version of Bayer's birth control pill Natazia...

News

U.S. Court Upholds Pfizer's Lyrica Patent Protection

19.07.2012 - Pfizer beat back a challenge from generic drugmakers to a patent that protects its pain medicine Lyrica, its second-best selling drug when a federal judge ruled in its favor on...